Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Arm Holdings plc's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $314.7B | |
|---|---|---|
| Revenue (ttm) | 5.2B | |
| Net income (ttm) | 1B | |
| EPS (ttm) | $0.98 | |
| Shares out | 1.1B | |
| P/E (trailing) | 240.8x | |
| P/E (forward) | 151.5x | |
| Volume | 3,374,178 | |
| Beta | 3.79 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | Trend |
| Revenue | $2.70B | $2.68B | $3.23B | $4.01B | $4.92B | +16.2% |
| Gross profit | $2.48B | $2.48B | $3.00B | $3.80B | $4.55B | +16.3% |
| Operating income | $786.0M | $671.0M | $212.0M | $720.0M | $1.16B | +10.1% |
| Net income | $549.0M | $524.0M | $306.0M | $792.0M | $904.0M | +13.3% |
| EPS (diluted) | — | $0.51 | $1.25 | $1.64 | $1.53 | +44.2% |
| EBITDA | $962.5M | $841.2M | $374.0M | $902.9M | $1.41B | +9.9% |
| R&D | $945.0M | $1.08B | $1.93B | $2.01B | $2.78B | +30.9% |
| SG&A | $897.0M | $762.0M | $983.0M | $984.0M | $1.12B | +5.6% |
Recent company headlines from major financial publishers.
The base case represents the house modal path where Arm successfully transitions licensees to the v9 architecture, achieving double-digit royalty growth despite a mature smartphone market. Capex gradually normalizes from FY2026 peak levels ($545M), allowing free cash flow conversion to improve over time. Consensus FY2028 EPS of $3.05 is achieved, and long-term operating margins reach 36.0%, yielding an intrinsic fair value of $54.92.
In the bull case, rapid adoption of custom silicon across hyperscalers (demonstrated by Google Axion and extensive Neoverse core deployments) accelerates revenue expansion well beyond consensus. Royalty growth sustains elevated momentum through FY2029, while custom silicon revenue breaks out as a distinct revenue line in FY2028. Operating margins expand substantially as upfront R&D investments yield high-margin compounding cash flows, driving strong EPS growth.
| Ke ↓ / g → | 3.5% | 3.5% | 3.5% | 3.5% | 3.5% |
|---|---|---|---|---|---|
| 16.2% | $55.1 | $55.1 | $55.1 | $55.2 | $55.2 |
| 16.2% | $55.1 | $55.1 | $55.1 | $55.1 | $55.1 |
| 16.2% | $55.1 | $55.1 | $54.9 | $55.1 | $55.1 |
| 16.2% | $55.0 | $55.1 | $55.1 | $55.1 | $55.1 |
| 16.2% | $55.0 | $55.0 | $55.0 | $55.0 | $55.0 |
Upcoming earnings date and setup when available.
The rating each month's published research edition carried. A rating compares the price at analysis with the Fair value; it is not a record of whether the call was right.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
